Marc Hedrick
Vermögen: 163 420 $ am 31.05.2026
Vermögen: 163 420 $ am 31.05.2026
Marc H.
Hedrick was the founder of StemSource, Inc., founded in 2000, where the titles held included President, Chief Executive Officer & Director from 2001 to 2003.
Dr. Hedrick currently holds the positions of President, Chief Executive Officer & Director at Plus Therapeutics, Inc. since 2019.
Former jobs include President, Chief Executive Officer & Director at Cytori Therapeutics, Inc. (JP); Chief Scientific Officer & Medical Director at MacroPore Biosurgery, Inc. from 2002 to 2004; Co-Director at UCLA Anderson School of Management; Director at Cytori Ltd.; and Associate Professor at the University of California, Los Angeles.
Education includes a doctorate from The University of Texas Southwestern Medical Center conferred in 1988 and an MBA from UCLA Anderson School of Management conferred in 2005.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.05.2026 | 28’044 ( 0.41% ) | 163 216 $ | 31.05.2026 | |
| 25.07.2018 | 35 ( -.--% ) | 204 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| PLUS THERAPEUTICS, INC. | Vorstandsvorsitzender | 02.04.2014 |
| Unternehmen | Position | Ende |
|---|---|---|
MacroPore Biosurgery, Inc. /Old/
MacroPore Biosurgery, Inc. /Old/ Medical SpecialtiesHealth Technology Manufactures biocompatible surgical implants for the reconstruction and regeneration of bones | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 |
StemSource, Inc.
StemSource, Inc. Miscellaneous Commercial ServicesCommercial Services Develops treatements to cancer | Gründer | 01.01.2003 |
UCLA Anderson School of Management
UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Cytori Therapeutics, Inc. (JP)
Cytori Therapeutics, Inc. (JP) BiotechnologyHealth Technology Provides cell therapy treatments and services | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 8 |
|---|---|
MacroPore Biosurgery, Inc. /Old/
MacroPore Biosurgery, Inc. /Old/ Medical SpecialtiesHealth Technology Manufactures biocompatible surgical implants for the reconstruction and regeneration of bones | Health Technology |
StemSource, Inc.
StemSource, Inc. Miscellaneous Commercial ServicesCommercial Services Develops treatements to cancer | Commercial Services |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Plus Therapeutics, Inc.
Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
The University of Texas Southwestern Medical Center
The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cytori Ltd.
Cytori Ltd. Pharmaceuticals: OtherHealth Technology Develops biological products | Health Technology |
Cytori Therapeutics, Inc. (JP)
Cytori Therapeutics, Inc. (JP) BiotechnologyHealth Technology Provides cell therapy treatments and services | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen